The Research Antibodies and Reagents by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Research Antibodies and Reagents Market:
According to The Business Research Company’s Research Antibodies and Reagents, The research antibodies and reagents market size has grown strongly in recent years. It will grow from $15.19 billion in 2023 to $16.44 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increase in pharmaceutical r&d expenditure, increased geriatric population, increased healthcare expenditure, increase in government funds for research and growth in the number of healthcare facilities.
The research antibodies and reagents market size is expected to see strong growth in the next few years. It will grow to $24.04 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to the increasing geriatric population, increasing prevalence of cancer and chronic diseases, increasing research and development spending, rise in healthcare expenditure, increasing financing for proteomics ventures, rising requirement for customized medicine and emergence of infectious diseases. Major trends in the forecast period include focusing on considering nanotechnology for identifying low-abundant molecules, launching innovative technological products to improve sales and profitability, focus on using advanced antibody purification technologies, consider acquiring and merging with other research agencies and centers and investing in r&d labs and initiatives..
Increasing investment in medical and health research and development (R&D) is predicted to contribute to the growth of the research antibodies and reagents market. In the field of life science research, antibodies and reagents are essential components for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. For instance, in April 2021, according to a report published by the Congressional Budget Office, a US-based government agency that provides budget and economic information, pharmaceutical companies will have invested $83 billion on research and development activities around the world. Thus, increasing investment in healthcare research and development will increase the utilization of the research antibodies and reagents market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3418&type=smp
The research antibodies and reagents market covered in this report is segmented –
1) By Technology: Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others
2) By Application: Proteomics, Genomics, Other Applications
3) By End User: Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, Contract Research Organizations (CROs)
Technological advancements in the area of purification of antibodies and reagents show opportunities for the growth of the research antibodies and reagents market during the forecast period. Irreproducible antibodies and reagents are a major challenge for the industry, as this will affect the outcome of the research. For instance, in April 2021, Native Antigen Company, a UK-based developer and manufacturer of antigens and antibodies, launched a SARS-CoV-2 Neutralisation Assay Development Kit, which includes all the necessary reagents for measuring Spike-antibody binding. The kit is specifically designed for the identification and qualitative measurement of neutralizing antibodies, with a focus on the RBD-ACE2 interaction.
The research antibodies and reagents market report table of contents includes:
- Executive Summary
- Research Antibodies and Reagents Market Characteristics
- Research Antibodies and Reagents Market Trends And Strategies
- Research Antibodies and Reagents Market - Macro Economic Scenario
- Global Research Antibodies and Reagents Market Size and Growth
.
.
.
- Global Research Antibodies and Reagents Market Competitive Benchmarking
- Global Research Antibodies and Reagents Market Competitive Dashboard
- Key Mergers And Acquisitions In Research Antibodies and Reagents Market
- Research Antibodies and Reagents Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Thermo Fisher Scientific Inc.
- Abcam plc
- Cell Signaling Technology, Inc.
- Merck KGaA
- Santa Cruz Biotechnology, Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
According to the new market research report "Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the global market size is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R activity and expenditure in the life sciences industry.
Fueled by the growing demand for personalized medicine and structure-based drug design, the global market is expected to witness significant growth in the coming years.Browse in-depth TOC on "Research Antibodies and Reagents Market"220 – Tables 45 – Figures 278 – PagesDownload PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection.
As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19.
The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.The antibodies segment is expected to grow at the highest CAGR during the forecast periodBased on product, the research antibodies market is segmented into reagents and antibodies.
The primary antibodies segment held the largest share of the global research antibodies market in 2019.
Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoptionThe media & sera reagent is expected to account for the largest share of the market, by type, in 2019Based type, the research antibodies and reagents market is segmented into media , stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents.
Global Research Antibodies and Reagents Scope and Market SizeResearch Antibodies and Reagents market is segmented by company, region (country), by Type, and by Application.
Players, stakeholders, and other participants in the global Research Antibodies and Reagents market will be able to gain the upper hand as they use the report as a powerful resource.
The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6350840/global-linear-particle-accelerators-2021-633Segment by TypeFlow CytometryELISAImmunofluorescenceWestern BlottingOthersSegment by ApplicationPharmaceutical & Biotechnological CompaniesAcademic & Research InstitutesContract Research OrganizationsOthersBy RegionNorth AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of AsiaLatin AmericaMexicoBrazilRest of Latin AmericaMiddle East & AfricaTurkeySaudi ArabiaUAERest of MEABy CompanyThermo Fisher ScientificMerck MilliporeDanaherSiemens HealthcareBio-Rad LaboratoriesRocheSysmexPerkinElmerAbcamBDAgilent TechnologiesReasons to Purchase Our Research Report:1.
Market dynamics scenario, along with growth opportunities of the market in the years to come3.
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.
Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.
